| Literature DB >> 22863276 |
Harindra C Wijeysundera1, Gina Trubiani, Lusine Abrahamyan, Nicholas Mitsakakis, William Witteman, Mike Paulden, Gabrielle van der Velde, Kori Kingsbury, Murray Krahn.
Abstract
BACKGROUND: Multi-disciplinary heart failure (HF) clinics have been shown to improve outcomes for HF patients in randomized clinical trials. However, it is unclear how widely available specialized HF clinics are in Ontario. Also, the service models of current clinics have not been described. It is therefore uncertain whether the efficacy of HF clinics in trials is generalizable to the HF clinics currently operating in the province.Entities:
Mesh:
Year: 2012 PMID: 22863276 PMCID: PMC3506498 DOI: 10.1186/1472-6963-12-236
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Seed heart failure clinics
| 1. | Cornwall: Cornwall Community Hospital |
| 2. | Hamilton: Heart Function Clinic - Hamilton Health Sciences Corporation |
| 3. | Kingston: Hotel Dieu Hospital |
| 4. | Kitchener: St. Mary's Hospital |
| 5. | London: London Health Sciences Centre |
| 6. | Oakville: Oakville-Trafalgar Memorial Hospital |
| 7. | Orillia: Orillia Soldiers' Memorial Hospital |
| 8. | Ottawa: University of Ottawa Heart Institute |
| 9. | Owen Sound: Grey Bruce Health Services |
| 10. | Picton: Prince Edward Family Health Team Heart Failure Clinic |
| 11. | Toronto: University Health Network (UHN) (1) |
| 12. | Toronto: University Health Network (UHN) (2) |
| 13. | Toronto: Mt Sinai Heart Function Clinic |
| 14. | Toronto: St Michael’s Hospital Heart Function Clinic |
| 15. | Toronto: Sunnybrook Hospital Heart Function Clinic |
Heart failure disease management scoring instrument (HF-DMSI)
| 1 = Provider alone | |
| | 2 = Patient alone |
| | 3 = Patient with some inclusion of caregiver |
| | 4 = Patient with a caregiver who is central to the intervention |
| 0 = No mention of education | |
| | 1 = Focus solely on importance of treatment adherence |
| | 2 = Focus on treatment adherence including some creative methods of improving adherence |
| | 3 = Focus on surveillance but no mention of actions to be taken in response to symptoms (eg, no flexible diuretic management) |
| | 4 = Emphasis on surveillance, management, and evaluation of symptoms in addition to treatment adherence |
| 0 = No mention of medication regimen | |
| | 1 = Some mention of medications (eg, importance of medication compliance) but not an active part of the intervention. No attempt to intervene with provider to get patients on an evidence-based medication regimen |
| | 2 = Evidence-based medication regimen advocated but no follow-up with patient or provider to monitor the suggestion |
| | 3 = Medication regimen monitored, attempt made to get the patient on evidence-based medications, with follow-up monitoring done with patient or provider |
| 0 = No mention of a peer support intervention | |
| | 1 = Peer support mentioned but not integral to intervention |
| | 2 = Peer support integral component of intervention |
| 0 = No use of remote monitoring or telehealth | |
| | 1 = Remote monitoring is used in conjunction with other interventions that form the main intervention used |
| | 2 = Telehealth is essential component of intervention |
| 1 = Single generalist provider (eg, physician, nurse, pharmacist) | |
| | 2 = Single HF expert provider (eg, physician, nurse, pharmacist) |
| | 3 = Multidisciplinary intervention |
| 1 = Mechanized via internet or telephone | |
| | 2 = Person-to-person by telephone |
| | 3 = Face-to-face, individual, or in a group |
| | 4 = Combined: Face-to-face at least once alone or in a group with individual telephone calls in between meetings |
| 1 = ≤1 mo | |
| | 2 = ≤3 mo |
| | 3 = ≤6 mo |
| | 4= > 6 mo |
| 1 = Low: single contact with little or no follow-up | |
| | 2 = Moderate: >1 but <4 and/or infrequent contact or contacts of short duration |
| | 3 = High: multiple contacts of significant duration |
| 1 = Hospital: Inpatient only | |
| | 2 = Clinic/outpatient setting |
| | 3 = Home-based |
| 4 = Combination of settings | |
Figure 1Process by which 28 clinics were identified by snowball sampling. Based on interview responses from the initial 15 seed clinics, full saturation was reached in 3 generations.
Figure 2Regional Local Health Integration Networks (LHIN) in Ontario depicting regional distribution of identified heart failure clinics.
Geographic distribution of clinics
| Erie St. Clair | 0 | 623,300 | NA | 85,000 | NA | NA |
| South West | 3 | 890,100 | 296,700 | 125,800 | 41,900 | 247 |
| HNHB | 2 | 1,298,300 | 649,100 | 192,400 | 96,200 | 591 |
| Waterloo Wellington | 5 | 679,700 | 135,900 | 76,000 | 15,200 | 84 |
| Mississauga Halton | 3 | 1,002,300 | 334,100 | 103,400 | 34,500 | 155 |
| Central West | 0 | 735,200 | NA | 65,900 | NA | NA |
| Central | 2 | 1,522,800 | 761,400 | 183,100 | 91,600 | 395 |
| Central East | 3 | 1,419,800 | 473,300 | 184,600 | 61,500 | 305 |
| Toronto Central | 6 | 1,075,100 | 179,200 | 131,800 | 22,000 | 118 |
| North Simcoe Muskoka | 3 | 417,000 | 139,000 | 59,900 | 20,000 | 108 |
| South East | 2 | 457,200 | 228,600 | 74,700 | 37,400 | 217 |
| Champlain | 3 | 1,131,400 | 377,100 | 137,600 | 45,900 | 247 |
| North East | 1 | 545,000 | 545,000 | 84,900 | 84,900 | 626 |
| North West | 1 | 231,900 | 231,900 | 31,400 | 31,400 | 218 |
| Total | 34 | 12,028,900 | 353,800 | 1,536,500 | 45,200 | 200 |
LHIN: Local Health Integration Network; HF: Heart Failure; HNHB: Hamilton Niagara Haldimand Brant; NA: not applicable.
Figure 3Annual Service Volume of the identified Heart Failure Clinics. The red bar indicates new patients per year, and the blue bar represents annual patient visits.
Characteristics of 30 identified clinics
| | |
| Mean number of Physicians | 4.7 (1–8)* |
| % of clinics with cardiologist | 80.6 |
| % of clinics with internists | 22.6 |
| % of clinics with family physicians | 9.7 |
| % of physicians with heart failure training | 80.6 |
| Mean Number of Nurses | 2.0 (1–6)* |
| % Academic | 25.8 |
| % Community Based | 74.2 |
| Mean Annual Total Visits | 1020 (200–1479)* |
| Mean Annual Total New Patients | 139 (25–128)* |
| % Access to Onsite Echocardiography | 80.6 |
| % Access to Onsite Nuclear Cardiology Testing | 58.1 |
| % Access to Onsite Angiography | 38.7 |
| % Access to Onsite exercise Stress Testing | 77.4 |
| Mean Exam Rooms | 3.3 (1–4)* |
| % Access to Dietician (In Clinic) | 45.2 |
| % Access to Pharmacist (In Clinic) | 32.3 |
| % Access to Physiotherapy (In Clinic) | 6.5 |
| % Access to Counselor (In Clinic) | 16.1 |
| % Affiliated with Cardiac Rehabilitation | 87.1 |
| % Involved in other Chronic Disease Management | 64.5 |
* inter-quartile range is shown.
Figure 4Distribution of scores on 10 categories of Heart Failure Disease Management Scoring Instrument (HF-DMSI). Please refer to Table 2 for specific definitions of individual scores. Higher scores indicate more comprehensive program within that category.
Clinic intensity and complexity
| | |||||
|---|---|---|---|---|---|
| | | ||||
| Recipient | 3.3 ± 0.6 | 3.7 ± 0.5 | 3.2 ± 0.6 | 3.0 ± 0.6 | .040 |
| Education and counselling aimed at supporting self-care | 3.2 ± 1.0 | 3.9 ± 0.3 | 3.1 ± 1.0 | 2.6 ± 1.1 | .011 |
| Medication management | 2.7 ± 0.5 | 3.0 ± 0 | 2.8 ± 0.4 | 2.1 ± 0.7 | .002 |
| Peer support | 0.3 ± 0.5 | 0.6 ± 0.7 | 0.2 ± 0.4 | 0.3 ± 0.5 | .147 |
| Remote monitoring | 0.7 ± 0.8 | 1.0 ± 0.8 | 0.8 ± 0.8 | 0.1 ± 0.4 | .079 |
| Delivery personnel | 2.5 ± 0.6 | 3.0 ± 0 | 2.5 ± 0.5 | 2.0 ± 0.8 | .002 |
| Method of communication | 3.6 ± 0.5 | 4.0 ± 0 | 3.5 ± 0.5 | 3.4 ± 0.5 | .018 |
| Duration | 4.0 ± 0 | 4.0 ± 0 | 4.0 ± 0 | 4.0 ± 0 | - |
| Complexity | 2.6 ± 0.6 | 3.0 ± 0 | 2.6 ± 0.5 | 2.0 ± 0.6 | <.001 |
| Environment | 2.0 ± 0.2 | 2.0 ± 0 | 1.9 ± 0.3 | 2.0 ± 0 | .536 |
HF-DMSI : Heart Failure Disease Management Scoring Instrument. Results are presented as means ± standard deviations. Please refer to Table 2 for detail description of HF-DMSI categories and scoring.